EurekaMag.com logo
+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Pseudo-receptor modeling: a new concept for the three-dimensional construction of receptor binding sites



Pseudo-receptor modeling: a new concept for the three-dimensional construction of receptor binding sites



Journal of Receptor Research 13(1-4): 163-177



Molecular design of small molecules intended to target a macromolecule generally utilizes one of two computational approaches: "receptor fitting" or "receptor mapping". A comprehensive strategy for the design of potent, selective and novel ligands for cell-bound receptors combines the two by means of "pseudoreceptor modeling". Definition of a refined pharmacophore model is the first step. A subsequent step involves the construction of a pseudoreceptor--an explicit molecular binding pocket--for the bioactive conformation of a series of ligands with high affinity for a particular receptor subtype. The receptor-mapping program "Yak" allows the construction of a peptidic pseudoreceptor around any single small molecule or molecular ensemble of interest. The fidelity of the approach is exemplified by application to the active site of the enzymes human carbonic anhydrase I and thermolysin, followed by comparison with their known X-Ray crystal structures.

(PDF emailed within 0-6 h: $19.90)

Accession: 033019485

Download citation: RISBibTeXText

PMID: 8383750

DOI: 10.3109/10799899309073653



Related references

Rat brain guanosine binding site. Biological studies and pseudo-receptor construction. Bioorganic & Medicinal Chemistry 11(24): 5417-5425, 2003

Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 and steroid receptor coactivator 1 Multiple motifs with different binding specificities. Molecular Endocrinology 12(2): 302-313, 1998

Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Molecular Endocrinology 12(2): 302-313, 1998

Growth hormone binding to a circulating receptor fragment--the concept of receptor shedding and receptor splicing. Experimental and Clinical Endocrinology & Diabetes 103(1): 2-6, 1995

P2 receptor modeling and identification of ligand binding sites. Turner, J T, Weisman, G A, Fedan, J S The Receptors Series; The P2 nucleotide receptors 135-166, 1998

Ligand recognition in mu opioid receptor: experimentally based modeling of mu opioid receptor binding sites and their testing by ligand docking. Bioorganic & Medicinal Chemistry 4(12): 2151-2166, 1996

Prediction of the three-dimensional structure for the rat urotensin II receptor, and comparison of the antagonist binding sites and binding selectivity between human and rat receptors from atomistic simulations. Chemmedchem 5(9): 1594-1608, 2011

Assays of 125I-Bolton-Hunter substance P binding sites, functional sites of tachykinin NK1 receptor: Quantitative receptor autoradiographic method. Acta Medica Nagasakiensia 42(3-4): 10-15, 1997

Molecular Modeling of Anesthetic Binding Sites within a Composite Glycine Receptor. Anesthesiology Abstracts of Scientific Papers Annual Meeting ( ): Abstract No A-121, 2002

Modeling the G-protein-coupled neuropeptide Y Y1 receptor agonist and antagonist binding sites. Protein Engineering 10(2): 109-117, 1997

Analysis of epstein barr virus binding sites on complement receptor 2 cr2 cd21 using human mouse chimeras and peptides a least two distinct sites are necessary for ligand receptor interaction. Journal of Biological Chemistry 266(19): 12173-12179, 1991

Genetic mapping of starch receptor and lambda receptor sites in maltoporin identification of substitutions causing direct and indirect effects on binding sites by cysteine mutagenesis. Molecular Microbiology 5(9): 2293-2301, 1991

A review of mutagenesis studies of angiotensin II type 1 receptor, the three-dimensional receptor model in search of the agonist and antagonist binding site and the hypothesis of a receptor activation mechanism. Journal of Hypertension 15(7): 703-714, 1997

Determination of antibody binding sites on the three-dimensional and primary structure of acetylcholine receptor. Monographs in Allergy 25: 20-32, 1988